欣诺宁通过对多巴胺水平的调节效应降低了甲胺诱导的高位运动
Byoung Mo Choi1, Sun Mi Gu1, Abdulaziz Jabborov1
1College of Pharmacy, Chungbuk National University, 194-31 Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28160, Republic of Korea.
ACS chemical neuroscience
|January 22, 2025
概括
来自hinoki的欣诺宁因调节多巴胺水平和多巴胺转运体 (DAT) 功能而降低甲基胺诱导的过活性. 这种天然化合物显示出减轻中枢神经系统因滥用甲基胺而受到刺激的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 滥用甲基胺 (METH) 导致严重的社会和健康负担.
- 缺乏有效的METH诱导的中枢神经系统 (CNS) 刺激的治疗方法.
- 黑梅 (hinoki) 含有欣诺基宁,一种具有潜在中枢神经系统抑郁性质的化合物.
研究的目的:
- 为了研究欣诺基提取物和欣诺基宁在调节METH诱导的超运动中的潜力.
- 探索多巴胺基神经元活动在欣诺金宁效应中的作用.
- 确定欣诺基宁影响多巴胺和多巴胺转运体 (DAT) 功能的机制.
主要方法:
- 对小鼠进行了欣诺基宁预治疗.
- 在METH给药后测量运动运动活动.
- 在状脑切片中分析了多巴胺水平和DAT功能.
- 用于分析,拉下测试和剂量反应曲线来评估欣诺-DAT相互作用.
主要成果:
- 欣诺基宁的预治疗显著减轻了METH诱导的超位动.
- 欣诺基宁抑制了METH诱导的多巴胺水平升高和DAT功能下降.
- 通过各种测试证实了欣诺宁与DAT的直接结合.
结论:
- 欣诺基宁通过抑制多巴胺基神经传递来缓解METH诱导的高位运动.
- 达特的阿洛斯特基调节是欣诺基宁作用的关键机制.
- 欣诺基宁显示出作为治疗剂的承诺,用于控制多巴胺介导的中枢神经系统刺激.
相关概念视频
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
158
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
158
01:25Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
01:29Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
247
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
247
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
01:29Stimulants
157
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
157